Cargando…
Potent Molecular Feature-based Neutralizing Monoclonal Antibodies as Promising Therapeutics Against SARS-CoV-2 Infection
The 2019–2020 winter was marked by the emergence of a new coronavirus (SARS-CoV-2) related disease (COVID-19), which started in Wuhan, China. Its high human-to-human transmission ability led to a worldwide spread within few weeks and has caused substantial human loss. Mechanical antiviral control ap...
Autores principales: | Kombe Kombe, Arnaud John, Zahid, Ayesha, Mohammed, Ahmed, Shi, Ronghua, Jin, Tengchuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201996/ https://www.ncbi.nlm.nih.gov/pubmed/34136533 http://dx.doi.org/10.3389/fmolb.2021.670815 |
Ejemplares similares
-
Editorial: Host-microbe interaction in SARS-CoV-2 infection: mechanism and intervention
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2023) -
Pharmacological Inhibitors of the NLRP3 Inflammasome
por: Zahid, Ayesha, et al.
Publicado: (2019) -
Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2021) -
CD8(+) T-cell immune escape by SARS-CoV-2 variants of concern
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2022) -
Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity
por: Mengist, Hylemariam Mihiretie, et al.
Publicado: (2021)